Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiviral chemotherapy

B U Mueller1

  • 1Children's Hospital, Department of Medicine, Boston, MA 02115, USA.

Current Opinion in Pediatrics
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

New antiviral drugs, including protease inhibitors and improved understanding of reverse transcriptase inhibitors, enhance HIV treatment for children and adults. These advancements offer more effective therapeutic options for managing HIV disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding.

Digestive diseases and sciences·2021
Same author

NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.

Bone marrow transplantation·2017
Same author

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.

Bone marrow transplantation·2015
Same author

High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma.

British journal of cancer·2011
Same author

The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML.

British journal of cancer·2010
Same author

PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.

Oncogene·2009

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Significant progress has been made in antiviral therapies.
  • The chemotherapeutic options for viral infections have expanded recently.

Purpose of the Study:

  • To review recent advances in the treatment of Human Immunodeficiency Virus (HIV) disease.
  • To discuss novel antiviral agents and improved understanding of existing drugs for HIV therapy.

Main Methods:

  • Literature review of new antiviral agents.
  • Analysis of previously approved drugs for HIV treatment.
  • Focus on protease inhibitors and reverse transcriptase inhibitors.

Main Results:

  • New antiviral agents, particularly protease inhibitors, demonstrate pronounced antiviral effects.

Related Experiment Videos

  • Enhanced understanding of reverse transcriptase inhibitors contributes to improved treatment outcomes.
  • Advances benefit both pediatric and adult HIV patients.

    • Conclusions:

    • Recent developments in antiviral pharmacology have significantly improved HIV disease management.
    • The combination of novel agents and refined use of existing drugs offers more effective HIV treatment strategies.